Neurocrine Biosciences
NBIX
#1569
Rank
NZ$22.89 B
Marketcap
NZ$229.62
Share price
0.59%
Change (1 day)
-14.80%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company